ArticleArthritis research & therapy2025

Baricitinib could improve the prognosis of anti-MDA5 antibody positive dermatomyositis associated interstitial lung disease.

Shuai Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.